The role of ATP binding cassette (ABC) transporters in breast cancer: Evaluating prognosis, predicting immunity, and guiding treatment

References

• Katsura C, Ogunmwonyi I, Kankam HK, et al. Breast cancer: presentation, investigation and management. Br J Hosp Med. 2022;83(2):1–11. doi: 10.12968/hmed.2021.0459
   PubMed Web of Science ®Google Scholar
• Corti C, PPMB G, AMM E, et al. Therapeutic vaccines for breast cancer: has the time finally come? Eur J Cancer. 2022;160:150–174. doi: 10.1016/j.ejca.2021.10.027
   PubMed Web of Science ®Google Scholar
• Rasool R, Ullah I, Mubeen B, et al. Theranostic interpolation of genomic instability in breast cancer. Int J Mol Sci. 2022 [Published 2022 Feb 7];23(3):1861. doi: 10.3390/ijms23031861
   PubMed Web of Science ®Google Scholar
• Troxell ML, Gupta T. Neoadjuvant therapy in breast cancer: histologic changes and clinical implications. Surg Pathol Clin. 2022;15(1):57–75. doi: 10.1016/j.path.2021.11.004
   PubMedGoogle Scholar
• Decker T, Schmidt M. New opportunities in advanced breast cancer. Oncol Res Treat. 2022;45(1–2):1–3. doi: 10.1159/000521414
   PubMed Web of Science ®Google Scholar
• Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol. 2022;95(1130):20211033. doi: 10.1259/bjr.20211033
   PubMed Web of Science ®Google Scholar
• Liu J, Zheng X, Lin S, et al. Breast conserving therapy for central breast cancer in the United States.BMC Surg. 2022 [Published 2022 Jan 29];22(1):31. doi: 10.1186/s12893-022-01488-0
   PubMed Web of Science ®Google Scholar
• Rakha E, Toss M, Quinn C. Specific cell differentiation in breast cancer: a basis for histological classification. J Clin Pathol. 2022;75(2):76–84. doi: 10.1136/jclinpath-2021-207487
   PubMed Web of Science ®Google Scholar
• Bauer E, Levy MS, Domachevsky L, et al. Background parenchymal enhancement and uptake as breast cancer imaging biomarkers: a state-of-the-art review. Clin Imaging. 2022;83:41–50. doi: 10.1016/j.clinimag.2021.11.021
   PubMed Web of Science ®Google Scholar
• Emens LA. Breast cancer immunotherapy: facts and hopes. Clin Cancer Res. 2018;24(3):511–520. doi: 10.1158/1078-0432.CCR-16-3001
   PubMed Web of Science ®Google Scholar
• Keenan TE, Tolaney SM. Role of immunotherapy in triple-negative breast cancer. J Natl Compr Canc Netw. 2020;18(4):479–489. doi: 10.6004/jnccn.2020.7554
   PubMed Web of Science ®Google Scholar
• Sugie T. Immunotherapy for metastatic breast cancer. Chin Clin Oncol. 2018;7(3):28. doi: 10.21037/cco.2018.05.05
   PubMed Web of Science ®Google Scholar
• Marra A, Viale G, Curigliano G. Recent advances in triple negative breast cancer: the immunotherapy era.BMC Med. 2019 [Published 2019 May 9];17(1):90. doi: 10.1186/s12916-019-1326-5
   PubMed Web of Science ®Google Scholar
• Wang JQ, Wu ZX, Yang Y, et al. ATP-binding cassette (ABC) transporters in cancer: a review of recent updates. J Evid Based Med. 2021;14(3):232–256. doi: 10.1111/jebm.12434
   PubMedGoogle Scholar
• Qiu Y, Li H, Xie J, et al. Identification of ABCC5 among ATP-Binding cassette transporter family as a New biomarker for Hepatocellular Carcinoma based on bioinformatics analysis. Int J Gen Med. 2021 [Published 2021 Oct 27];14:7235–7246. doi: 10.2147/IJGM.S333904
   PubMed Web of Science ®Google Scholar
• Vultaggio-Poma V, Sarti AC, Di VF. Extracellular ATP: a feasible target for cancer therapy.Cells. 2020 [Published 2020 Nov 17];9(11):2496. doi: 10.3390/cells9112496
   PubMed Web of Science ®Google Scholar
• Stefková J, Poledne R, JA H. ATP-binding cassette (ABC) transporters in human metabolism and diseases. Physiol Res. 2004;53(3):235–243. doi: 10.33549/physiolres.930432
   PubMed Web of Science ®Google Scholar
• Hong M. Biochemical studies on the structure-function relationship of major drug transporters in the ATP-binding cassette family and solute carrier family. Adv Drug Deliv Rev. 2017;116:3–20. doi: 10.1016/j.addr.2016.06.003
   PubMed Web of Science ®Google Scholar
• M Braden A, V Stankowski R, M Engel J, et al. Breast cancer biomarkers: risk assessment, diagnosis, prognosis, prediction of treatment efficacy and toxicity, and recurrence. Curr Pharm Des. 2014;20(30):4879–4898. doi: 10.2174/1381612819666131125145517
   PubMed Web of Science ®Google Scholar
• Peairs KS, Choi Y, Stewart RW, et al. Screening for breast cancer. Semin Oncol. 2017;44(1):60–72. doi: 10.1053/j.seminoncol.2017.02.004
   PubMed Web of Science ®Google Scholar
• Menta A, Fouad TM, Lucci A, et al. Inflammatory breast cancer: what to know about this unique, aggressive breast cancer. Surg Clin North Am. 2018;98(4):787–800. doi: 10.1016/j.suc.2018.03.009
   PubMed Web of Science ®Google Scholar
• Tray N, Taff J, Adams S. Therapeutic landscape of metaplastic breast cancer. Cancer Treat Rev. 2019;79:101888. doi: 10.1016/j.ctrv.2019.08.004
   PubMed Web of Science ®Google Scholar
• Kolak A, Kamińska M, Sygit K, et al. Primary and secondary prevention of breast cancer. Ann Agric Environ Med. 2017;24(4):549–553. doi: 10.26444/aaem/75943
   PubMed Web of Science ®Google Scholar
• Liang Y, Zhang H, Song X, et al. Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Semin Cancer Biol. 2020;60:14–27. doi: 10.1016/j.semcancer.2019.08.012
   PubMed Web of Science ®Google Scholar
• DeSantis C, Siegel R, Bandi P, et al. Breast cancer statistics, 2011. CA Cancer J Clin. 2011;61(6):409–418. doi: 10.3322/caac.20134
   PubMed Web of Science ®Google Scholar
• Park JH, Pyun WY, Park HW. Cancer metabolism: phenotype, signaling and therapeutic targets.Cells. 2020 [Published 2020 Oct 16];9(10):2308. doi: 10.3390/cells9102308
   PubMed Web of Science ®Google Scholar
• Koppenol WH, Bounds PL, Dang CV. Otto Warburg’s contributions to current concepts of cancer metabolism [published correction appears in. Nat Rev Cancer. 2011 Aug;11(8):325–337. doi: 10.1038/nrc3038
   PubMed Web of Science ®Google Scholar
• Courtnay R, Ngo DC, Malik N, et al. Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K. Mol Biol Rep. 2015;42(4):841–851. doi: 10.1007/s11033-015-3858-x
   PubMed Web of Science ®Google Scholar
• Bose S, Zhang C, Le A. Glucose metabolism in cancer: the Warburg effect and beyond. Adv Exp Med Biol. 2021;1311:3–15. doi: 10.1007/978-3-030-65768-0_1
   PubMed Web of Science ®Google Scholar
• Li J, Xie J, Wu D, et al. A pan-cancer analysis revealed the role of the SLC16 family in cancer. Channels (Austin). 2021;15(1):528–540. doi: 10.1080/19336950.2021.1965422
   PubMed Web of Science ®Google Scholar
• Chen L, Yang Z, Cao Y, et al. Pan-cancer analysis and single-cell analysis revealed the role of ABCC5 transporter in hepatocellular carcinoma. Channels (Austin). 2021;15(1):541–554. doi: 10.1080/19336950.2021.1968592
   PubMed Web of Science ®Google Scholar
• Locher KP. Mechanistic diversity in ATP-binding cassette (ABC) transporters. Nat Struct Mol Biol. 2016;23(6):487–493. doi: 10.1038/nsmb.3216
   PubMed Web of Science ®Google Scholar
• Schneider E, Hunke S. ATP-binding-cassette (ABC) transport systems: functional and structural aspects of the ATP-hydrolyzing subunits/domains. FEMS Microbiol Rev. 1998;22(1):1–20. doi: 10.1111/j.1574-6976.1998.tb00358.x
   PubMed Web of Science ®Google Scholar
• Cole SP. Multidrug resistance protein 1 (MRP1, ABCC1), a “multitasking” ATP-binding cassette (ABC) transporter. J Biol Chem. 2014;289(45):30880–30888. doi: 10.1074/jbc.R114.609248
   PubMed Web of Science ®Google Scholar
• Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002;2(1):48–58. doi: 10.1038/nrc706
   PubMed Web of Science ®Google Scholar
• Basu A, Ramamoorthi G, Jia Y, et al. Immunotherapy in breast cancer: Current status and future directions. Adv Cancer Res. 2019;143:295–349. doi: 10.1016/bs.acr.2019.03.006
   PubMed Web of Science ®Google Scholar
• Franzoi MA, Romano E, Piccart M. Immunotherapy for early breast cancer: too soon, too superficial, or just right? Ann Oncol. 2021;32(3):323–336. doi: 10.1016/j.annonc.2020.11.022
   PubMed Web of Science ®Google Scholar
• Quaglino E, Conti L, Cavallo F. Breast cancer stem cell antigens as targets for immunotherapy. Semin Immunol. 2020;47:101386. doi: 10.1016/j.smim.2020.101386
   PubMed Web of Science ®Google Scholar
• Wei W, Xu R, Ying X, et al. Transcriptome analysis of Solute carrier-associated genes in hepatocellular carcinoma: friend or foe? Front Genet. 2022;13:856393. doi: 10.3389/fgene.2022.856393
   PubMedGoogle Scholar